
About Synergia Sciences
Synergia Sciences is a Healthcare company based in Ahmedabad (India) founded in 2010. Insecticide ingredients for household and veterinary health are manufactured. It operates on a Reseller / Distribution model in Healthcare and Chemicals & Materials sectors. Synergia Sciences has raised $193.93 thousand across 1 funding round from investors including Sunrise Pharmaceutical. The company has 75 employees. Synergia Sciences was last valued at $9.88 million in July 2021. Its Indian entity Synergia Sciences Private Limited reported revenue of βΉ135 Cr. Synergia Sciences offers products and services including Household Insecticides Ingredients and Animal Health Ingredients. Its focus areas include Manufacturing, Chemical Manufacturing and Specialty Chemicals.
Company details
Synergia Sciences is involved in the production of active ingredients for household insecticides and animal health products. The company serves global markets, targeting top multinational corporations. Operations are based in India with facilities and offices established to support manufacturing and distribution. Expertise in product development and quality assurance is leveraged from experience in the regulated pharmaceutical industry.
- Headquarters Ahmedabad, India
- Employees 75
- Stage Minicorn
- SectorsHealthcareChemicals & Materials
- Website synergiasciences.com
- Legal Name Synergia Sciences Private Limited
- Date of Incorporation 29 Oct, 2010
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹135 Cr
FY 2025 · +53% YoY
- Net Profit₹26.67 Cr
FY 2025 · 20% margin
- EBITDA₹42.06 Cr
FY 2025 · 31% margin
- Total Equity Funding$193.93K (USD)
in 1 rounds
- Latest Funding Round$193.93K (USD), Seed
Jul 2021
- Investors
- Employee Count75
Associated legal entities of Synergia Sciences
Synergia Sciences operates through Synergia Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synergia Sciences Private Limited CIN U24100MH2010PTC209590 | Active | 29 Oct 2010 | Mumbai, Maharashtra | ₹135 Cr | 75 | 3 | View details |
Products & Services of Synergia Sciences
Synergia Sciences offers a comprehensive portfolio of products and services, including Household Insecticides Ingredients and Animal Health Ingredients.
Active ingredients for household insecticides are manufactured here.
Active ingredients for animal health products are produced.
Funding Insights of Synergia Sciences
Synergia Sciences has successfully raised a total of $193.93K through 1 strategic funding round. The most recent funding activity was a Seed round of $193.93 thousand completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $193,931
- Total Rounds 1
- Last Round Seed β $193,931
- First Round $193,931
(Jul 2021)
- Investors Count 1
All 1 funding rounds of Synergia Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $193,931 | Seed | $9.88M | Sunrise Pharmaceutical | β |
| Date | Valuation | Stage |
|---|---|---|
| Jul 2021 | $9.88M | β’β’β’β’β’β’β’β’ |
Last known valuation $9.88M (Jul 2021). 1 investors in total: 1 institutional.
Investors in Synergia Sciences
Synergia Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sunrise Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sunrise Pharmaceutical develops, manufactures, markets, and distributes generic drugs globally. | 2007 | sunrisepharma.com | Rahway, United States |
Investor details for Synergia Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Synergia Sciences Private Limited (Synergia Sciences)
Synergia Sciences Private Limited is the primary company behind Synergia Sciences. The board of Synergia Sciences Private Limited currently have 3 directors; the longest-serving is Nandini Parekh Sandip, appointed in 2014. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nandini Parekh Sandip DIN 06807527 | Director | 07 Feb 2014 | 12 yrs 8 mo | Synergia Sciences Private Limited |
| Sharang Sandeep Parekh DIN 07147582 | Director | 22 Jun 2017 | 9 yrs 4 mo | Synergia Sciences Private Limited |
| Janesh Natverlal Upadhyay DIN 09513490 | Director | 28 Feb 2022 | 4 yrs 7 mo | Synergia Sciences Private Limited |
Financials of Synergia Sciences
Figures of Synergia Sciences Private Limited, the primary company behind Synergia Sciences, for FY 2025. Revenue was ₹135 Cr (+53% year on year). Net profit was ₹26.67 Cr (20% margin). EBITDA was ₹42.06 Cr (31% margin). Revenue has grown at a compounded annual rate of +24% over three years and +30% over five years.
- ₹135 CrRevenue · FY 2025 · +53% YoY
- ₹26.67 CrNet profit · 20% margin
- ₹42.06 CrEBITDA · 31% margin
- ₹1.53 CrPaid-up capital
- 75Employees (provident fund records)
- +24%Revenue CAGR, 3 years
- +30%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synergia Sciences Private Limited are on its company page.
Detailed financial statements for Synergia Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Synergia Sciences
3 dated milestones of Synergia Sciences across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Synergia Sciences is founded.
- Funding First funding round of $194K.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synergia Sciences
Synergia Sciences was founded in 2010 and raised its 1st funding round 11 years after it was founded.
Synergia Sciences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Synergia Sciences is a funded company, having raised a total of $193.93K across 1 funding round to date. The company's 1st funding round was a Seed of $193.93K, raised on Jul 2021.
Synergia Sciences has 75 employees.
The primary company behind Synergia Sciences, Synergia Sciences Private Limited, reported revenue of βΉ135 Cr for FY 2025, up 53% year on year.
Synergia Sciences is involved in the production of active ingredients for household insecticides and animal health products. The company serves global markets, targeting top multinational corporations. Operations are based in India with facilities and offices established to support manufacturing and distribution. Expertise in product development and quality assurance is leveraged from experience in the regulated pharmaceutical industry.
Synergia Sciences offers Household Insecticides Ingredients and Animal Health Ingredients.
Synergia Sciences has 1 investor. Key investors include Sunrise Pharmaceutical.
The valuation of Synergia Sciences is $9.88M as of Jul 2021.
Synergia Sciences operates through Synergia Sciences Private Limited.
The legal entities of Synergia Sciences currently have 3 directors, including Nandini Parekh Sandip, Janesh Natverlal Upadhyay, Sharang Sandeep Parekh.